Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

Blood

Volumn 118, Issue 25, 2011, Pages 6702-6708

  Ferrara, James L M ^a   Harris, Andrew C ^a   Greenson, Joel K ^a   Braun, Thomas M ^b   Holler, Ernst ^c   Teshima, Takanori ^d   Levine, John E ^a   Choi, Sung W J ^a   Huber, Elisabeth ^c   Landfried, Karin ^c   Akashi, Koichi ^d   Vander Lugt, Mark ^a   Reddy, Pavan ^a   Chin, Alice ^e   Zhang, Qing ^e   Hanash, Samir ^e   Paczesny, Sophie ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d KYUSHU UNIVERSITY   (Japan)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; LECTIN; REGENERATING ISLET DERIVED 3 ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; RISK FACTOR; SCHOOL CHILD; SKIN DISEASE; STAGING; SURVIVAL;

EID: 84055177580     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-375006     Document Type: Article

References (39)

1. Cutler C, Antin JH. Manifestation and treatment of acute graft-versus-host-disease. In: Appelbaum F, Forman SJ, Negrin RS, Blume KG, eds. Thomas' Hematopoietic Cell Transplantation. Oxford, United Kingdom: Blackwell Publishing Ltd; 2009:1287-1303.
2. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139-170. (Pubitemid 46697905)
3. Mowat A, Socie G. Intestinal graft-vs.-host disease. In: Ferrara JLM, Cooke KR, Deeg HJ, eds. Graft-vs-Host Disease. New York, NY: Marcel Dekker; 2004:279-327.
4. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561.
5. Martin PJ, McDonald GB, Sanders JE, et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2004;10(5):320-327. (Pubitemid 38519570)
6. MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transpl. 2002;8(7):387-394.
7. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15(6):825-828.
8. Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transpl. 2006;12(1):31-47. (Pubitemid 43034096)
9. Washington K, Jagasia M. Pathology of graftversus- host disease in the gastrointestinal tract. Hum Pathol. 2009;40(7):909-917.
10. Ertault-Daneshpouy M, Leboeuf C, Lemann M, et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood. 2004;103(12):4681-4684. (Pubitemid 38746004)
11. Weisdorf D, Haake R, Blazar B, et al. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood. 1990;75(4):1024-1030. (Pubitemid 20067206)
12. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109(10):4119- 4126. (Pubitemid 46743372)
13. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313(5790):1126- 1130. (Pubitemid 44300239)
14. Gironella M, Iovanna JL, Sans M, et al. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease. Gut. 2005;54(9):1244-1253. (Pubitemid 41192482)
15. Faca V, Coram M, Phanstiel D, et al. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res. 2006;5(8):2009-2018. (Pubitemid 44232714)
16. Faca V, Pitteri SJ, Newcomb L, et al. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res. 2007;6(9):3558-3565. (Pubitemid 47522747)
17. Paczesny S, Braun T, Levine JE, et al. Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Medicine. 2010;2(13):50-57.
18. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6(4):367-371.
19. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood. 2009;113(2):273-278.
20. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
21. Skidgel RA, Erdos EG. Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int Immunopharmacol. 2007;7(14):1888-1899. (Pubitemid 350138511)
22. Marchbank T, Freeman TC, Playford RJ. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair. Digestion. 1998;59(3):167-174. (Pubitemid 28246384)
23. Mykkanen OM, Gronholm M, Ronty M, et al. Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell. 2001;12(10):3060-3073. (Pubitemid 33062961)
24. Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H. Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem. 1990;265(13):7432-7439.
25. Christa L, Carnot F, Simon MT, et al. HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol. 1996;271(6 Pt 1):G993-G1002. (Pubitemid 27034374)
26. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol. 2000;1(2):113-118.
27. Weisdorf SA, Salati LM, Longsdorf JA, Ramsay NK, Sharp HL. Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin. Gastroenterology. 1983;85(5):1076-1081. (Pubitemid 13007799)
28. MacMillan ML, DeFor TE, Weisdorf DJ. The best endpoint for acute GVHD treatment trials. Blood. 2010;115(26):5412-5417.
29. Levine JE, Logan B, Wu J, et al. Graft-versus-host disease treatment: predictors of survival. Biol Blood Marrow Transplant. 2010;16(12):1693-1699.
30. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107(5):1398-1407. (Pubitemid 24328277)
31. Barker CC, Anderson RA, Sauve RS, Butzner JD. GI complications in pediatric patients post-BMT. Bone Marrow Transplant. 2005;36(1):51-58. (Pubitemid 40946050)
32. Luft T, Conzelmann M, Benner A, et al. Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood. 2007;110(13):4535-4542. (Pubitemid 351377821)
33. Sanos SL, Vonarbourg C, Mortha A, Diefenbach A. Control of epithelial cell function by interleukin-22-producing RORgammat(+) innate lymphoid cells. Immunology. 2011;132(4):453-465.
34. Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14(3):282-289. (Pubitemid 351347912)
35. Takashima S, Kadowaki M, Aoyama K, et al. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells. J Exp Med. 2011;208(2):285-294.
36. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst. 1974;52(2):401-404.
37. Gerbitz A, Schultz M, Wilke A, et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood. 2004;103(11):4365-4367. (Pubitemid 38685386)
38. Elphick DA, Mahida YR. Paneth cells: their role in innate immunity and inflammatory disease. Gut. 2005;54(12):1802-1809. (Pubitemid 41697682)
39. Closa D, Motoo Y, Iovanna JL. Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine. World J Gastroenterol. 2007;13(2):170-174. (Pubitemid 46231320)